Menu

Lasker Winners Announced

DNA-damage response and cancer immunotherapy discoveries are among those recognized by the Albert and Mary Lasker Foundation this year.

Sep 8, 2015
Tracy Vence

Left to right: Stephen Elledge, Evelyn Witkin, James AllisonALBERT AND MARY LASKER FOUNDATIONEvelyn Witkin of Rutgers University in New Jersey and Stephen Elledge of the Brigham and Women’s Hospital in Boston have won the 2015 Lasker Award for basic medical research. The Albert and Mary Lasker Foundation is recognizing Witkin and Elledge for their pioneering work on the DNA-damage response. (See “Gene Silencing Is Golden,” The Scientist, August 2013; “Damage Control,” The Scientist, March 2009.)

The University of Texas MD Anderson Cancer Center’s James Allison has won the 2015 Lasker Award for clinical medical research. He is being honored for his work toward antibody-based immunotherapies for cancer. (See “Deploying the Body’s Army,” The Scientist, April 2014.)

“I’ve always considered [my work] really basic science, so it’s really quite an honor to receive the clinical award this year,” Allison said during a press conference today (September 8). “I see it in part as an acknowledgement of advances in immunotherapy . . . as a field.”

Médecins Sans Frontières (MSF, also known as Doctors Without Borders) has won this year’s Lasker-Bloomberg Public Service Award for “bold leadership in responding to the recent Ebola outbreak in Africa, and for sustained and effective frontline responses to health emergencies,” the foundation said in a statement.

“It’s important for society to promote the culture of science and to celebrate its values,” Elledge said during the press conference. “The Lasker Foundation is really promoting the values of science that really motivated me.”

The 2015 Lasker Awards will be presented September 18 in New York City.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.